$0.33 Pharma stock that has some VERY interesting analyst price targets + some good FDA feedback on phase 3 clinical trials
New video:
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
$0.33 Pharma stock that has some VERY interesting analyst price targets + some good FDA feedback on phase 3 clinical trials
New video: